NYSE · MFC
Manulife Financial financials
$43.42−0.18%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.71B | $33.58B | $32.12B | $18.41B | $40.10B | $61.99B | $61.19B | $28.73B | $46.37B | $39.72B |
| Gross profit | $40.71B | $33.58B | $32.12B | $18.41B | $6.98B | $9.12B | $13.08B | $6.01B | $10.44B | $7.64B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 17.4% | 14.7% | 21.4% | 20.9% | 22.5% | 19.2% |
| Operating income | $1.48B | $1.86B | $1.97B | -$5.11B | $5.57B | $12.70B | $12.28B | $11.12B | $9.37B | $9.09B |
| Net income | $3.83B | $3.54B | $3.62B | -$1.62B | $5.45B | $4.48B | $4.18B | $3.41B | $1.55B | $2.08B |
| Net margin | 9.4% | 10.5% | 11.3% | −8.8% | 13.6% | 7.2% | 6.8% | 11.9% | 3.3% | 5.2% |
| Diluted EPS | $2.24 | $1.98 | $1.97 | $-0.85 | $2.80 | $2.30 | $2.13 | $1.72 | $0.78 | $1.05 |
| EBITDA | $149.4M | $805.5M | $896.6M | -$6.20B | $5.99B | $13.21B | $12.76B | $11.67B | $9.82B | $9.61B |
| Operating cash flow | $23.39B | $18.46B | $15.41B | $12.25B | $18.32B | $15.75B | $15.80B | $14.15B | $14.15B | $12.67B |
| Free cash flow | $23.39B | $18.46B | $15.41B | $12.25B | -$77.39B | -$72.22B | -$46.19B | -$60.44B | -$55.21B | $12.67B |
| Diluted shares | 1,708.0M | 1,785.0M | 1,838.0M | 1,913.0M | 1,946.0M | 1,943.0M | 1,962.0M | 1,988.0M | 1,986.0M | 1,977.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Jan 1 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $19.45B | $17.97B | $15.35B | $14.11B | $17.88B | $20.56B |
| Short-term investments | $336.05B | $303.81B | $284.94B | $256.87B | $316.31B | $0.00 |
| Total debt | $5.60B | $4.62B | $4.58B | $9.11B | $9.39B | $10.99B |
| Total assets | $747.10B | $682.07B | $660.81B | $614.38B | $734.40B | $691.55B |
| Total liabilities | $708.86B | $645.16B | $624.04B | $578.84B | $697.30B | $649.91B |
| Shareholders' equity | $38.24B | $36.90B | $36.78B | $35.54B | $37.10B | $41.64B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology